BDO’s M&A and Capital Markets team is pleased to announce that Tevosol, Inc. (“Tevosol”) was acquired by Bridge to Life, Ltd. in an all-share transaction. The transaction was completed in November of 2020.
Tevosol is currently known for the development of EVOSS (Ex-Vivo Organ Support System) to preserve, assess, and reclaim donor organs for transplant. The system is the weight and size of a regular ice cooler, affordable, and maintains the organ at normal body temperatures. The company completed its first human transplants in 2019, secured key strategic partnerships and capital financing in 2020, and aims to manufacture, trial, and commercialize EVOSS Lung in 2021. Product research and development, design and engineering, assembly and packaging, and global distribution will remain wholly based in Edmonton, Alberta.
BDO’s M&A and Capital Markets team acted as exclusive financial advisor to Tevosol, assisting the company’s management and shareholders through the entire divestiture process.